ATE396746T1 - Verwendung eines resinats zur herstellung einer formulierung zur beendigung des rauchens - Google Patents

Verwendung eines resinats zur herstellung einer formulierung zur beendigung des rauchens

Info

Publication number
ATE396746T1
ATE396746T1 AT02716134T AT02716134T ATE396746T1 AT E396746 T1 ATE396746 T1 AT E396746T1 AT 02716134 T AT02716134 T AT 02716134T AT 02716134 T AT02716134 T AT 02716134T AT E396746 T1 ATE396746 T1 AT E396746T1
Authority
AT
Austria
Prior art keywords
resinate
formulation
producing
quitting smoking
water
Prior art date
Application number
AT02716134T
Other languages
English (en)
Inventor
Simon Andrew Bellamy
Lyn Hughes
Mazin Nicola
Original Assignee
Rohm & Haas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rohm & Haas filed Critical Rohm & Haas
Application granted granted Critical
Publication of ATE396746T1 publication Critical patent/ATE396746T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Addiction (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
AT02716134T 2002-01-18 2002-01-18 Verwendung eines resinats zur herstellung einer formulierung zur beendigung des rauchens ATE396746T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/GB2002/000199 WO2003061709A1 (en) 2002-01-18 2002-01-18 A method for preparing resinates

Publications (1)

Publication Number Publication Date
ATE396746T1 true ATE396746T1 (de) 2008-06-15

Family

ID=27589640

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02716134T ATE396746T1 (de) 2002-01-18 2002-01-18 Verwendung eines resinats zur herstellung einer formulierung zur beendigung des rauchens

Country Status (7)

Country Link
US (1) US20050169997A1 (de)
EP (1) EP1467769B1 (de)
JP (1) JP4268052B2 (de)
CN (1) CN1615156B (de)
AT (1) ATE396746T1 (de)
DE (1) DE60226899D1 (de)
WO (1) WO2003061709A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005013934A2 (en) * 2003-07-28 2005-02-17 Novartis Consumer Health S.A. Taste-masked composition of cationic exchange resin
ATE439839T1 (de) 2003-12-02 2009-09-15 Fertin Pharma As Nikotin-abgabeprodukt und herstellungsverfahren
WO2006128468A1 (en) * 2005-06-01 2006-12-07 Fertin Pharma A/S A method of manufacturing a nicotine delivery product
US20070003512A1 (en) * 2005-06-20 2007-01-04 Stockel Richard F Bisphosphonate resinates
CN117563570B (zh) * 2024-01-16 2024-03-15 西安金沃泰环保科技有限公司 一种用于蛋白吸附的树脂及其制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2990332A (en) * 1958-04-02 1961-06-27 Wallace & Tiernan Inc Pharmaceutical preparations comprising cation exchange resin adsorption compounds and treatment therewith
DE1617513C3 (de) * 1965-08-20 1974-04-18 F. Hoffmann-La Roche & Co. Ag, Basel (Schweiz) Arzneimittelzubereitung
NL167303C (nl) * 1970-07-22 Leo Ab Vormstukken van kauwgom, bestaande uit een kauwgomba- sismassa, een tabaksalkaloide en eventueel andere ge- bruikelijke bestanddelen van kauwgom.
US4980562A (en) * 1986-04-09 1990-12-25 Varian Associates, Inc. Method and apparatus for high efficiency scanning in an ion implanter
IL90245A (en) * 1988-05-11 1994-04-12 Glaxo Group Ltd Resin adsorption containing ranitidine together with synthetic resin replaces cations, its preparation and pharmaceutical preparations containing it
GB8925484D0 (en) * 1989-11-10 1989-12-28 Glaxo Group Ltd Process
US5980882A (en) * 1997-04-16 1999-11-09 Medeva Pharmaceuticals Manufacturing Drug-resin complexes stabilized by chelating agents
WO2000040224A1 (en) * 1999-01-07 2000-07-13 Elan Corporation, Plc Multiparticulate oral dosage forms
US20020031490A1 (en) * 2000-07-27 2002-03-14 Bellamy Simon Andrew Method for preparing resinates
US6607752B2 (en) * 2000-07-27 2003-08-19 Rohm And Haas Company Method for the anhydrous loading of nicotine onto ion exchange resins
US20020032245A1 (en) * 2000-07-27 2002-03-14 Lyn Hughes Resinate composition

Also Published As

Publication number Publication date
JP2005519068A (ja) 2005-06-30
CN1615156A (zh) 2005-05-11
EP1467769B1 (de) 2008-05-28
CN1615156B (zh) 2012-05-30
WO2003061709A1 (en) 2003-07-31
EP1467769A1 (de) 2004-10-20
JP4268052B2 (ja) 2009-05-27
DE60226899D1 (de) 2008-07-10
US20050169997A1 (en) 2005-08-04

Similar Documents

Publication Publication Date Title
WO2002022598A8 (en) Quinolinone derivatives as tyrosine kinase inhibitors
WO2002069888A3 (en) Serotonin reuptake inhibitor formulations
ATE525100T1 (de) Poröse matrix
DE602004016127D1 (de) Antagonisten der opioidrezeptoren
ATE367162T1 (de) Verwendubg von 3-hydroxy-3-methylglutaryl coenzym a reduktase inhibitoren zur herstellung eines medikaments zur behandlung der diabetischen neuropathie
NO962126L (no) Tannpasta med silika-slipemiddel
ATE319702T1 (de) Verfahren zur herstellung von benzothiophen- derivaten
DE60036029D1 (de) Basismaterialien zur geweberegeneration, transplantatmaterialien und verfahren zur herstellung selbiger
DK1381402T3 (da) Fremgangsmåde til forbedring af blødvævsmodtagelse og implantater der gør brug af denne fremgangsmåde
ATE396746T1 (de) Verwendung eines resinats zur herstellung einer formulierung zur beendigung des rauchens
DE602004024902D1 (de) Verbesserte formulierung zur bereitstellung eines magensaftresitenten beschichtungsmaterials
EP1988253A3 (de) Verdrehsicherungsspray für Zementierstopfen
GEP20074045B (en) (4-phenyl) piperidin-3-yl-phenylcarboxylate derivatives and related compounds as beta-secretase inhibitors for the treatment of alzheimer's disease
ITMI20030640A1 (it) Procedimento per l'utilizzo di estratti organici ottenuti per lisciviazione acquosa di legno finalizzato alla preparazione di soluzioni organiche acidificanti per l'agricoltura biologica e concimi ad alta
SE0201713D0 (sv) New methods and use III
DE602004023478D1 (de) Geschmacksmaskierte beschichtete teilchen, verfahren zur herstellung und in der mundhöhle dispergierbare tabletten enthaltend die beschichteten teilchen
ATE375165T1 (de) Verfahren zur herstellung eines extraktes aus efeublättern
WO2004066984A3 (en) Improved taste masking pharmaceutical composition and process for its preparation
AU2001277659A1 (en) Heteropolycyclic inhibitors
WO2004054354A3 (en) Carved pearl
WO2004062562A3 (en) Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
EA200800966A1 (ru) Новая композиция, содержащая росиглитазон и другое противодиабетическое средство
DE60237388D1 (de) Verfahren zur herstellung von zusammensetzungen mit erhöhtem gehalt von salzen pharmazeutisch aktiver rotamere
ATE295368T1 (de) Verfahren zur herstellung 3-amino-gallensaurer derivate
GB2422465A (en) Method and apparatus for dynamic application management in sub-sea well installations

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties